CLINICAL_TRIALS
withdrawal
· 2023-05-06
Clinical Trial Update: 802NP301 Efficacy and Safety Study of BIIB074 in Participants With Trigeminal Neuralgia [Phase 3]
Summary
Phase 3 trial of BIIB074 for trigeminal neuralgia was withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Biogen | Conditions: Trigeminal Neuralgia | Phase 3 | Status: WITHDRAWN